Europe pharmaceutical drug delivery market is expected to witness rapid growth during the forecast period. Key factors propelling the growth of this market include technological advancements in drug delivery systems and improving patient compliance. Furthermore, the rise in cases of COVID-19 has led to an increased adoption of drugs including multivitamin, antiviral, vitamin C, etc., which in turn is anticipated to support the growth of pharmaceutical drug delivery market. With increasing cases of coronavirus, there is a high demand for essential life-saving devices and other essential medical supplies in order to prevent the spread of this global pandemic. This is expected to foster the growth of Europe pharmaceutical drug delivery market through 2025.

Additionally, prevalence of other infectious and contagious diseases such as Ebola, chikungunya, SARS, MERS, avian flu and swine flu are creating high demand for pharmaceutical drug delivery systems. Also, increasing healthcare expenditure and favorable reimbursement policies are expected to augment the market growth in coming years. Apart from this, entry of new market players and extensive R&D activities are fueling the growth of pharmaceutical drug delivery market in Europe.

Europe pharmaceutical drug delivery market can be categorized based on formulation, route of administration, application, end user and country. Based on application, the market can be segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory. diseases, central nervous system disorders, autoimmune diseases and others. Among these, cancer held largest market share in 2019. However, the infectious diseases segment is anticipated to register fastest CAGR in Europe pharmaceutical drug delivery market during the forecast period on account of increasing cases of contagious diseases such as coronavirus and  extensive vaccine development activities being carried out to find its cure.

Major players operating in the Europe pharmaceutical drug delivery market include Novartis AG, F. Hoffman-La Roche AG, GlaxoSmithKline plc, Bayer AG, Sanofi S.A. , MERCK KGaA, Pfizer Inc., Johnson & Johnson, 3M United Kingdom PLC and Becton, Dickinson and Company, among others. The companies are investing on product innovation and are also undergoing mergers & acquisitions and partnerships as their key growth strategies.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and estimate the market size of Europe pharmaceutical drug delivery market from 2015 to 2018.
  • To estimate and forecast the market size of Europe pharmaceutical drug delivery market from 2019 to 2025 and growth rate until 2025.
  • to classify and forecast Europe pharmaceutical drug delivery market based on formulation, route of administration, application, end user, company and country distribution.
  • To identify dominant country or segment in the Europe pharmaceutical drug delivery market.
  • To identify drivers and challenges for Europe pharmaceutical drug delivery market.
  • To examine competitive developments such as expansions, mergers & acquisitions, etc., in Europe pharmaceutical drug delivery market.
  • To conduct pricing analysis for Europe pharmaceutical drug delivery market.
  • To identify and analyze the profile of leading players operating in Europe pharmaceutical drug delivery market.
  • To identify key sustainable strategies adopted by market players in Europe pharmaceutical drug delivery market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of pharmaceutical drug delivery system manufacturers across Europe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across Europe.

TechSci Research calculated the market size of Europe pharmaceutical drug delivery market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and end users for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Pharmaceutical drug delivery system manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to pharmaceutical drug delivery
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as pharmaceutical drug delivery system manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Europe pharmaceutical drug delivery market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Europe Pharmaceutical Drug Delivery Market, By Formulation:
    • Conventional Drug Delivery
    • Novel Drug Delivery
  • Europe Pharmaceutical Drug Delivery Market, By Route of Administration:
    • Oral
    • Injectable
    • Topical
    • Ocular
    • Pulmonary
    • Nasal
    • Transmucosal
    • Implantable
  • Europe Pharmaceutical Drug Delivery Market, By Application:
    • Infectious Diseases
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Respiratory Diseases
    • Central Nervous System Disorders
    • Autoimmune Diseases
    • Others
  • Europe Pharmaceutical Drug Delivery Market, By End User:
    • Hospitals
    • Home Care Settings
    • ASC/Clinics
    • Others
  • Europe Pharmaceutical Drug Delivery Market, By Country:
    • Italy
    • France
    • United Kingdom
    • Germany
    • Spain
    • Belgium
    • Netherlands

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Europe pharmaceutical drug delivery market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Europe Pharmaceutical Drug Delivery Market

4.    Executive Summary

5.    Voice of Customer

6.    Europe Pharmaceutical Drug Delivery Market Outlook

6.1.  Market Size & Forecast

6.1.1. By Value

6.2.  Market Share & Forecast

6.2.1. By Formulation (Conventional Drug Delivery, Novel Drug Delivery)

6.2.2. By Route of Administration (Oral, Injectable, Topical, Ocular, Pulmonary, Nasal, Transmucosal, Implantable)

6.2.3. By Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Others)

6.2.4. By End User (Hospitals, Home Care Settings, ASC/Clinics, Others)

6.2.5. By Company (2019)

6.2.6. By Country

6.3.  Product Market Map

7.    Italy Pharmaceutical Drug Delivery Market Outlook

7.1.  Market Size & Forecast          

7.1.1. By Value

7.2.  Market Share & Forecast

7.2.1. By Formulation

7.2.2. By Route of Administration

7.2.3. By Application

7.2.4. By End User

8.    United Kingdom Pharmaceutical Drug Delivery Market Outlook

8.1.  Market Size & Forecast          

8.1.1. By Value

8.2.  Market Share & Forecast

8.2.1. By Formulation

8.2.2. By Route of Administration

8.2.3. By Application

8.2.4. By End User

9.    France Pharmaceutical Drug Delivery Market Outlook

9.1.  Market Size & Forecast          

9.1.1. By Value

9.2.  Market Share & Forecast

9.2.1. By Formulation

9.2.2. By Route of Administration

9.2.3. By Application

9.2.4. By End User

10.  Spain Pharmaceutical Drug Delivery Market Outlook

10.1.              Market Size & Forecast

10.1.1.   By Value

10.2.              Market Share & Forecast

10.2.1.   By Formulation

10.2.2.   By Route of Administration

10.2.3.   By Application

10.2.4.   By End User

11.  Germany Pharmaceutical Drug Delivery Market Outlook

11.1.              Market Size & Forecast

11.1.1.   By Value

11.2.              Market Share & Forecast

11.2.1.   By Formulation

11.2.2.   By Route of Administration

11.2.3.   By Application

11.2.4.   By End User

12.  Belgium Pharmaceutical Drug Delivery Market Outlook

12.1.              Market Size & Forecast

12.1.1.   By Value

12.2.              Market Share & Forecast

12.2.1.   By Formulation

12.2.2.   By Route of Administration

12.2.3.   By Application

12.2.4.   By End User

13.  Netherlands Pharmaceutical Drug Delivery Market Outlook

13.1.              Market Size & Forecast

13.1.1.   By Value

13.2.              Market Share & Forecast

13.2.1.   By Formulation

13.2.2.   By Route of Administration

13.2.3.   By Application

13.2.4.   By End User

14.  Market Dynamics

14.1.              Drivers

14.2.              Challenges

15.  Pricing Analysis

16.  Market Trends & Developments

17.  Competitive Landscape

17.1.              Competition Outlook

17.2.              Regional Players Profiled (Leading Companies)

17.2.1.   Novartis AG

17.2.2.   F. Hoffman-La Roche AG

17.2.3.   GlaxoSmithKline plc

17.2.4.   Bayer AG

17.2.5.   Sanofi S.A.

17.2.6.   MERCK KGaA

17.2.7.   Pfizer Inc.

17.2.8.   Johnson & Johnson

17.2.9.   3M United Kingdom PLC

17.2.10. Becton, Dickinson and Company

18.  Strategic Recommendations

19.  About Us & Disclaimer

 (Note: The companies list can be customized based on the client requirements.)

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]